Series A Companies in South San Francisco

Petit Pot brings renowned French dessert traditions to the Bay Area.

Tacit Therapeutics created RNA-targeting treatments for devastating diseases.

Chariot Defense is creating the advanced hardware and software framework to solve it.

Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.

Discover the intent signals your CRM is missing

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

InterVene is a medical device company that treats severe venous disease in the legs.

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

Atomic AI combines machine learning with structural biology to enable the design of RNA-targeted small molecules and RNA-based therapeutics.

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.

Boost Biomes develops microbial products to sustainably improve food production and shelf-life.